FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000259575> ?p ?o ?g. }

• W2000259575 endingPage "335" @default.
• W2000259575 startingPage "322" @default.
• W2000259575 abstract "The present study was designed to improve the bioavailability of forskolin by the influence of precorneal residence time and dissolution characteristics. Nanosizing is an advanced approach to overcome the issue of poor aqueous solubility of active pharmaceutical ingredients. Forskolin nanocrystals have been successfully manufactured and stabilized by poloxamer 407. These nanocrystals have been characterized in terms of particle size by scanning electron microscopy and dynamic light scattering. By formulating Noveon AA-1 polycarbophil/poloxamer 407 platforms, at specific concentrations, it was possible to obtain a pH and thermoreversible gel with a pH(gel)/T (gel) close to eye pH/temperature. The addition of forskolin nanocrystals did not alter the gelation properties of Noveon AA-1 polycarbophil/poloxamer 407 and nanocrystal properties of forskolin. The formulation was stable over a period of 6 months at room temperature. In vitro release experiments indicated that the optimized platform was able to prolong and control forskolin release for more than 5 h. The in vivo studies on dexamethasone-induced glaucomatous rabbits indicated that the intraocular pressure lowering efficacy for nanosuspension/hydrogel systems was 31% and lasted for 12 h, which is significantly better than the effect of traditional eye suspension (18%, 4-6 h). Hence, our investigations successfully prove that the pH and thermoreversible polymeric in situ gel-forming nanosuspension with ability of controlled drug release exhibits a greater potential for glaucoma therapy." @default.
• W2000259575 created "2016-06-24" @default.
• W2000259575 creator A5000738290 @default.
• W2000259575 creator A5008034353 @default.
• W2000259575 creator A5036512877 @default.
• W2000259575 date "2010-02-25" @default.
• W2000259575 modified "2023-10-03" @default.
• W2000259575 title "Dual-Drug Delivery System Based on In Situ Gel-Forming Nanosuspension of Forskolin to Enhance Antiglaucoma Efficacy" @default.
• W2000259575 cites W1963490806 @default.
• W2000259575 cites W1967638230 @default.
• W2000259575 cites W1969453607 @default.
• W2000259575 cites W1991916654 @default.
• W2000259575 cites W2000313101 @default.
• W2000259575 cites W2002128115 @default.
• W2000259575 cites W2004684435 @default.
• W2000259575 cites W2015227492 @default.
• W2000259575 cites W2015820640 @default.
• W2000259575 cites W2021933371 @default.
• W2000259575 cites W2027938329 @default.
• W2000259575 cites W2038526752 @default.
• W2000259575 cites W2040432233 @default.
• W2000259575 cites W2041723821 @default.
• W2000259575 cites W2044594845 @default.
• W2000259575 cites W2046264407 @default.
• W2000259575 cites W2051025400 @default.
• W2000259575 cites W2054744079 @default.
• W2000259575 cites W2057266151 @default.
• W2000259575 cites W2065427736 @default.
• W2000259575 cites W2069800456 @default.
• W2000259575 cites W2076648466 @default.
• W2000259575 cites W2082276469 @default.
• W2000259575 cites W2086062588 @default.
• W2000259575 cites W2086606866 @default.
• W2000259575 cites W2088187401 @default.
• W2000259575 cites W2104838039 @default.
• W2000259575 cites W2128583478 @default.
• W2000259575 cites W2144996695 @default.
• W2000259575 cites W2148866245 @default.
• W2000259575 cites W4240782204 @default.
• W2000259575 doi "https://doi.org/10.1208/s12249-010-9388-x" @default.
• W2000259575 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2850500" @default.
• W2000259575 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20182824" @default.
• W2000259575 hasPublicationYear "2010" @default.
• W2000259575 type Work @default.
• W2000259575 sameAs 2000259575 @default.
• W2000259575 citedByCount "90" @default.
• W2000259575 countsByYear W20002595752012 @default.
• W2000259575 countsByYear W20002595752013 @default.
• W2000259575 countsByYear W20002595752014 @default.
• W2000259575 countsByYear W20002595752015 @default.
• W2000259575 countsByYear W20002595752016 @default.
• W2000259575 countsByYear W20002595752017 @default.
• W2000259575 countsByYear W20002595752018 @default.
• W2000259575 countsByYear W20002595752019 @default.
• W2000259575 countsByYear W20002595752020 @default.
• W2000259575 countsByYear W20002595752021 @default.
• W2000259575 countsByYear W20002595752022 @default.
• W2000259575 countsByYear W20002595752023 @default.
• W2000259575 crossrefType "journal-article" @default.
• W2000259575 hasAuthorship W2000259575A5000738290 @default.
• W2000259575 hasAuthorship W2000259575A5008034353 @default.
• W2000259575 hasAuthorship W2000259575A5036512877 @default.
• W2000259575 hasBestOaLocation W20002595752 @default.
• W2000259575 hasConcept C101335993 @default.
• W2000259575 hasConcept C127413603 @default.
• W2000259575 hasConcept C14631669 @default.
• W2000259575 hasConcept C155574463 @default.
• W2000259575 hasConcept C155672457 @default.
• W2000259575 hasConcept C15920480 @default.
• W2000259575 hasConcept C163588942 @default.
• W2000259575 hasConcept C171250308 @default.
• W2000259575 hasConcept C178790620 @default.
• W2000259575 hasConcept C185592680 @default.
• W2000259575 hasConcept C192562407 @default.
• W2000259575 hasConcept C202751555 @default.
• W2000259575 hasConcept C2779276759 @default.
• W2000259575 hasConcept C2779820397 @default.
• W2000259575 hasConcept C2780306666 @default.
• W2000259575 hasConcept C42360764 @default.
• W2000259575 hasConcept C43617362 @default.
• W2000259575 hasConcept C521977710 @default.
• W2000259575 hasConcept C55493867 @default.
• W2000259575 hasConceptScore W2000259575C101335993 @default.
• W2000259575 hasConceptScore W2000259575C127413603 @default.
• W2000259575 hasConceptScore W2000259575C14631669 @default.
• W2000259575 hasConceptScore W2000259575C155574463 @default.
• W2000259575 hasConceptScore W2000259575C155672457 @default.
• W2000259575 hasConceptScore W2000259575C15920480 @default.
• W2000259575 hasConceptScore W2000259575C163588942 @default.
• W2000259575 hasConceptScore W2000259575C171250308 @default.
• W2000259575 hasConceptScore W2000259575C178790620 @default.
• W2000259575 hasConceptScore W2000259575C185592680 @default.
• W2000259575 hasConceptScore W2000259575C192562407 @default.
• W2000259575 hasConceptScore W2000259575C202751555 @default.
• W2000259575 hasConceptScore W2000259575C2779276759 @default.
• W2000259575 hasConceptScore W2000259575C2779820397 @default.
• W2000259575 hasConceptScore W2000259575C2780306666 @default.
• W2000259575 hasConceptScore W2000259575C42360764 @default.

• next